morphine orion 20 mg/ ml
orion corporation - espoo - morfinhydroklorid - injeksjonsvæske, oppløsning - 20 mg/ ml
morphine orion 10 mg/ ml
orion corporation - espoo - morfinhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
morphine unimedic 1 mg/ ml
unimedic pharma ab - morfinhydrokloridtrihydrat - injeksjonsvæske, oppløsning - 1 mg/ ml
equisedan vet 10 mg/ ml
vetcare limited - detomidinhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaksiner - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
dropizol 10 mg/ ml
pharmanovia a/s - morfin som opiumtinktur, standardisert - dråper, oppløsning - 10 mg/ ml
morfin 10 mg/ ml
orifarm healthcare a/s - morfinhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
morfin abcur 10 mg/ ml
abcur ab - morfinhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
oramorph 2 mg/ ml
l. molteni & c. dei f.lli alitti società di esercizio s.p.a. - morfinsulfat - mikstur, oppløsning - 2 mg/ ml